How much bac water for 10 mg of tirzepatide — and why this question is a safety signal

You have probably been looking at powder vials sold cheaply online, here is what is actually happening

Picture the situation: you have found what looks like tirzepatide at a fraction of the price you have seen elsewhere, listed as a powder vial with a separate vial of bacteriostatic water. The seller provides a mixing guide. If you have been reading about how much bac water to use for a 10 mg tirzepatide vial, you are wondering whether 1 ml, 2 ml or some other volume is correct. It feels like a practical question. In reality, it is the wrong question to be asking about this medicine.

Tirzepatide is not, in the UK, available as a lyophilised (freeze-dried) powder for reconstitution. The Mounjaro Summary of Product Characteristics on the eMC describes a solution for injection in a pre-filled pen, manufactured and quality-controlled by Eli Lilly under strict pharmaceutical standards. What is sold in powder vials (sometimes labelled tirzepatide, sometimes with no label at all) is not that product. It may contain the wrong compound, the wrong concentration, or nothing clinically useful. It has not been through the MHRA's approval process, and mixing instructions from an online seller carry no regulatory authority.

The MHRA's enforcement work through 2025 found approximately 20 million doses of illegally traded weight-loss medicines, worth around £45 million, in unlicensed circulation, including the first UK site manufacturing counterfeit tirzepatide pens, raided in Northampton. Powder vials sit firmly in that category. No reconstitution calculation makes them safe, and our page on how much bac water to use for a 60 mg tirzepatide vial reaches the same clinical conclusion regardless of the volume involved.

What private tirzepatide actually costs in the UK, and what that price reflects

The honest picture on UK private pricing: Mounjaro is priced per pen, per month, and the amount varies by dose and provider. Eli Lilly raised its UK list price from 1 September 2025; reported market prices since then have ranged roughly £149 to £375 per month depending on dose and where treatment is sourced. These figures are widely cited but worth treating as a guide rather than a guarantee, your actual price depends on which dose a prescriber determines is appropriate for you.

That range will look expensive beside a powder vial sold for £30 on a social-media marketplace. The gap is not a market inefficiency. It reflects an unbroken licensed supply chain, pharmaceutical-grade manufacturing, a GPhC-registered pharmacy, clinical oversight, and the prescriber's professional accountability for your treatment. You can find more context on how the market is structured on our Mounjaro price guide.

At nume one price covers the consultation, the prescription, the medicine, and free next-working-day delivery. Your pen arrives in a plain, unbranded box via DPD with full tracking, in a pre-filled format with no mixing required. That is a deliberate design: the pen's dose was set by the manufacturer and verified by your prescriber, not calculated in someone's kitchen.

What headline prices from some providers do not include

Even within the legitimate private market, advertised prices sometimes exclude elements that add up. A consultation fee charged separately. A prescription fee on top. Delivery costs, particularly for temperature-controlled shipments. Aftercare access, or the cost of a follow-up clinical review before the next dose. Some providers charge each of these individually; some bundle some but not all.

At nume, the position is straightforward: one price, nothing added. We are not the cheapest option in the market, and that is a choice rather than an oversight. What the price pays for (genuine licensed medicine, same-day review by a named prescriber, 7-day aftercare) is the service. If cost is a concern, it is worth reading about the treatment options we offer and what each stage involves, so you can compare like for like rather than comparing a licensed pen with an unverified vial.

Why cheapest is the wrong measure for a prescription medicine

For most purchases, price is a reasonable proxy for value. For a prescription-only medicine injected into your body weekly, it is not. A lower number tells you nothing about whether the compound is what the label claims, whether the concentration is accurate, or whether the supply chain has maintained cold-chain integrity. It tells you nothing about who assessed whether it is safe for you specifically.

Tirzepatide is a Black Triangle medicine under additional MHRA monitoring, licensed for adults with a BMI of 30 or above (or 27 with a weight-related condition) following a proper clinical assessment, as set out in NICE technology appraisal TA1026. The prescriber's role is not a formality. They check your medical history, your current medicines, your weight, your suitability. That assessment is what makes the treatment appropriate rather than simply purchased. Reconstituted powder from an unverified seller skips every part of that, and if something goes wrong, there is no regulated professional accountable for your care.

If you have questions about any of this, our support team is available seven days a week. Or, if you are ready to explore whether licensed tirzepatide treatment is right for you, the most useful next step is a clinical conversation with our prescribers. You can also review commonly asked questions before you start. For detail on reconstitution volumes at other concentrations sometimes searched alongside this topic, see our pages on bac water for 5 mg tirzepatide and bac water for 15 mg tirzepatide, both of which reach the same clinical conclusion.